News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
851,259 Results
Type
Article (86746)
Company Profile (703)
Press Release (763808)
Multimedia
Podcasts (140)
Webinars (18)
Section
Business (232777)
Career Advice (4130)
Deals (39749)
Drug Delivery (129)
Drug Development (91063)
Employer Resources (198)
FDA (18160)
Job Trends (17355)
News (396716)
Policy (39799)
Tag
Academia (3002)
Academic (2)
Accelerated approval (9)
Adcomms (32)
Allergies (103)
Alliances (56945)
ALS (112)
Alzheimer's disease (1536)
Antibody-drug conjugate (ADC) (186)
Approvals (18108)
Artificial intelligence (377)
Autoimmune disease (34)
Automation (18)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (124)
Biotechnology (481)
Bladder cancer (95)
Brain cancer (37)
Breast cancer (377)
Cancer (2931)
Cardiovascular disease (235)
Career advice (3537)
Career pathing (34)
CAR-T (200)
CDC (37)
Cell therapy (551)
Cervical cancer (24)
Clinical research (74039)
Collaboration (1051)
Company closure (3)
Compensation (656)
Complete response letters (30)
COVID-19 (2894)
CRISPR (64)
C-suite (319)
Cystic fibrosis (117)
Data (2886)
Decentralized trials (2)
Denatured (49)
Depression (66)
Diabetes (338)
Diagnostics (6965)
Digital health (25)
Diversity (9)
Diversity, equity & inclusion (49)
Drug discovery (167)
Drug pricing (148)
Drug shortages (35)
Duchenne muscular dystrophy (125)
Earnings (97421)
Editorial (48)
Employer branding (25)
Employer resources (168)
Events (131287)
Executive appointments (891)
FDA (19776)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (964)
Gene editing (142)
Generative AI (37)
Gene therapy (419)
GLP-1 (903)
Government (5234)
Grass and pollen (6)
Guidances (180)
Healthcare (20913)
Huntington's disease (31)
IgA nephropathy (39)
Immunology and inflammation (172)
Immuno-oncology (8)
Indications (38)
Infectious disease (3071)
Inflammatory bowel disease (163)
Inflation Reduction Act (12)
Influenza (64)
Intellectual property (119)
Interviews (813)
IPO (17891)
IRA (54)
Job creations (5192)
Job search strategy (2861)
Kidney cancer (15)
Labor market (54)
Layoffs (582)
Leadership (25)
Legal (10130)
Liver cancer (84)
Lung cancer (415)
Lymphoma (201)
Machine learning (9)
Management (65)
Manufacturing (414)
MASH (92)
Medical device (14695)
Medtech (14700)
Mergers & acquisitions (22535)
Metabolic disorders (889)
Multiple sclerosis (101)
NASH (23)
Neurodegenerative disease (137)
Neuropsychiatric disorders (39)
Neuroscience (2250)
NextGen: Class of 2025 (7687)
Non-profit (5088)
Now hiring (47)
Obesity (467)
Opinion (286)
Ovarian cancer (97)
Pain (115)
Pancreatic cancer (114)
Parkinson's disease (191)
Partnered (25)
Patents (301)
Patient recruitment (144)
Peanut (54)
People (65611)
Pharmaceutical (143)
Pharmacy benefit managers (24)
Phase I (22863)
Phase II (32151)
Phase III (24203)
Pipeline (1610)
Policy (225)
Postmarket research (3552)
Preclinical (10321)
Press Release (72)
Prostate cancer (140)
Psychedelics (39)
Radiopharmaceuticals (277)
Rare diseases (496)
Real estate (7399)
Recruiting (75)
Regulatory (27020)
Reports (61)
Research institute (2663)
Resumes & cover letters (650)
Rett syndrome (9)
RNA editing (9)
RSV (54)
Schizophrenia (92)
Series A (164)
Series B (108)
Service/supplier (30)
Sickle cell disease (64)
Special edition (22)
Spinal muscular atrophy (167)
Sponsored (36)
Startups (4300)
State (2)
Stomach cancer (16)
Supply chain (80)
Tariffs (63)
The Weekly (89)
Vaccines (883)
Venture capital (53)
Weight loss (317)
Women's health (48)
Worklife (20)
Date
Today (52)
Last 7 days (515)
Last 30 days (2673)
Last 365 days (34274)
2025 (16798)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1272)
Alabama (67)
Alaska (7)
Arizona (279)
Arkansas (14)
Asia (50432)
Australia (8866)
California (7499)
Canada (2312)
China (687)
Colorado (322)
Connecticut (339)
Delaware (193)
Europe (115711)
Florida (1106)
Georgia (257)
Hawaii (1)
Idaho (65)
Illinois (714)
India (32)
Indiana (374)
Iowa (18)
Japan (218)
Kansas (115)
Kentucky (31)
Louisiana (17)
Maine (73)
Maryland (1075)
Massachusetts (5737)
Michigan (270)
Minnesota (469)
Mississippi (3)
Missouri (96)
Montana (32)
Nebraska (26)
Nevada (79)
New Hampshire (73)
New Jersey (2090)
New Mexico (31)
New York (2107)
North Carolina (1217)
North Dakota (10)
Northern California (3231)
Ohio (243)
Oklahoma (16)
Oregon (48)
Pennsylvania (1607)
Puerto Rico (18)
Rhode Island (39)
South America (1653)
South Carolina (35)
South Dakota (1)
Southern California (2763)
Tennessee (123)
Texas (1132)
United States (28354)
Utah (224)
Virginia (202)
Washington D.C. (80)
Washington State (662)
West Virginia (4)
Wisconsin (82)
There are 851,259 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Job Trends
Life Sciences Employment Growth in California Slows—and Could Keep Slowing
California’s life sciences jobs led the nation last year, according to a new California Life Sciences (CLS) report. However, employment growth slowed and could continue slowing. CLS President and CEO Mike Guerra discusses the critical factors influencing California’s success.
June 20, 2025
·
4 min read
·
Angela Gabriel
Business
Navigating Funding Freezes and AI Frontiers
In this episode of Denatured, BioSpace’s Head of Insights Lori Ellis discusses key themes from BIO and DIA, including the funding environment, with Rich Daly, CEO of Catalyst Pharmaceuticals, Peter Ronco, CEO of Emmes Corporation, and Phil Vanek, founder of Redline Bio Advisors.
June 20, 2025
·
1 min read
·
Lori Ellis
Press Releases
Superlab Suisse to Open New Facility at Campus Biotech in Geneva in January 2026
June 20, 2025
·
3 min read
Press Releases
Zemcelpro® (UM171 Cell Therapy) receives positive CHMP opinion for treatment of blood cancer patients without access to suitable donor cells
June 20, 2025
·
5 min read
Press Releases
RWJBarnabas Health, Rutgers Cancer Institute, Tufts Medical Center, and The University of Manchester Develop First Risk Prediction Model for Early-Stage Classic Hodgkin’s Lymphoma
June 20, 2025
·
10 min read
Press Releases
Poxel SA: New Scientific Presentations by Key Opinion Leaders to Further Highlight the Therapeutic Potential of Imeglimin at ADA 2025, the Leading Diabetes Conference
June 20, 2025
·
3 min read
Press Releases
Expanding Access in California: SmartVascular Dx™ Test Now Available Through Major Health Plans
June 20, 2025
·
3 min read
Press Releases
Intrinsic Therapeutics, Inc. Announces That ISASS Has Issued Updated 2025 Recommendations and Coverage Criteria for Barricaid Bone-Anchored Annular Closure
June 20, 2025
·
3 min read
Press Releases
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - June 19, 2025
June 20, 2025
·
3 min read
Press Releases
Telix Theranostic Programs and Satellite Symposia on Innovation in PSMA and CAIX Imaging Featured at SNMMI 2025
June 20, 2025
·
8 min read
1 of 85,126
Next
